Ursprung des Netzwerks ersten Grades von Yoshinori Oikawa
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY.
11
| Subsidiary | Biotechnology | 11 |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel.
6
| Holding Company | Biotechnology | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yoshinori Oikawa
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Private Equity Analyst | |
OrbiMed Israel Partners LP
 OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Investment Managers | Corporate Officer/Principal | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Chairman | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree | |
| APOSENSE LTD | Pharmaceuticals: Major | Director/Board Member | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Galmed Medical Research Ltd. | Director/Board Member | ||
| POLYPID LTD. | Pharmaceuticals: Major | Chairman | |
Manufacturers Association of Israel
 Manufacturers Association of Israel Miscellaneous Commercial ServicesCommercial Services The Manufacturers Association of Israel is an organization that has been serving as an umbrella organization for industrialists for over 90 years. The non-profit company is based in Tel Aviv, Israel. It has around 2,000 member companies in the industry and hi-tech sectors, employing approximately 400,000 workers. The association provides a wide range of support and services at both the national and corporate levels. Every year, the association awards the Industry Awards and the Lifetime Achievement Awards in Industry. Israeli industry plays a significant role in various aspects of life, including defense, immigrant absorption, support for outlying regions, education, and the community. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chairman | |
Israel Diamond Manufacturers Association Ltd.
 Israel Diamond Manufacturers Association Ltd. Miscellaneous Commercial ServicesCommercial Services Israel Diamond Manufacturers Association Ltd. engages in the advancement of the diamonds industry and the unification of diamonds producers. The company was founded in 1940 and is headquartered in Ramat Gan, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member | |
| GALMED PHARMACEUTICALS LTD. | Pharmaceuticals: Major | Chairman | |
| CH Health | Chief Executive Officer | ||
| Shirat Hachaim Ltd. | Chairman | ||
| The Institute for the Advancement of Education in Jaffa | Chairman | ||
Nucleix Ltd.
 Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | Medical/Nursing Services | Director/Board Member | |
Emerald Medical Applications Ltd.
 Emerald Medical Applications Ltd. Medical SpecialtiesHealth Technology Emerald Medical Applications Ltd. was engaged in the provision of medical apparatus software solutions. The company was founded by Adi Zamir and Lior Wayn on February 17, 2010 and was headquartered in Modi'in-Maccabim-Re'ut, Israel. | Medical Specialties | Director/Board Member | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VIEWBIX INC. | Computer Peripherals | Director/Board Member | |
SmartZyme Biopharma, Inc.
 SmartZyme Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services SmartZyme Biopharma, Inc. provides platform for protein design and engineering in accordance with industry required specifications. The company was founded by David Baram and Shilo Ben Zeev in 2013 and is headquartered in Ness Ziona, Israel. | Miscellaneous Commercial Services | Director/Board Member Founder | |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Director/Board Member | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| GENENTA SCIENCE S.P.A. | Pharmaceuticals: Major | Chairman Director/Board Member | |
NeuroRx, Inc.
 NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Aerodentis | Chairman | ||
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
| BIOMX INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
| Compugen Usa, Inc. | President |
Statistik
International
| Vereinigte Staaten | 26 |
| Israel | 23 |
| Vereinigtes Königreich | 3 |
| Italien | 2 |
Sektoral
| Health Technology | 31 |
| Finance | 6 |
| Commercial Services | 5 |
| Consumer Services | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 144 |
| Independent Dir/Board Member | 38 |
| Corporate Officer/Principal | 25 |
| Chairman | 22 |
| Founder | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Stephen P. Squinto | 40 |
| Erez Chimovits | 30 |
| Chaim Hurvitz | 25 |
| Todd Wider | 15 |
| Robbie Woodman | 12 |
| Joseph Oved | 9 |
| Earn Perry | 7 |
| Ei Yamada | 6 |
| Dorit Rozner | 5 |
| David Baram | 4 |
| Didi Daboush | 1 |
| Tetsuharu Yoneo | 1 |
| Rachel Diamant | 1 |
| Lior Izhar | 1 |
- Börse
- Insiders
- Yoshinori Oikawa
- Unternehmensverbindungen